Pharmacokinetics, Pharmacodynamics, and Safety of Entospletinib, a Novel pSYK Inhibitor, Following Single and Multiple Oral Dosing in Healthy Volunteers
Crossref DOI link: https://doi.org/10.1007/s40261-016-0476-x
Published Online: 2016-10-26
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ramanathan, Srini
Di Paolo, Julie A.
Jin, Feng
Shao, Lixin
Sharma, Shringi http://orcid.org/0000-0002-8162-5672
Robeson, Michelle
Kearney, Brian P.
Funding for this research was provided by:
Gilead Sciences (US)
License valid from 2016-10-26